Trials / Completed
CompletedNCT01820546
Cancer Stem Cells in Multiple Myeloma
Flow Cytometric Definition and Prognostic Effects of Multiple Myeloma Cancer Stem Cells
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 96 (actual)
- Sponsor
- Ankara University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In multiple myeloma "cancer stem" cells can be defined and quantified with flow cytometry. More, these cells can be related to treatment response.
Detailed description
The investigators' hypothesis is that, multiple myeloma plasma cells derivate from principal cells that is called "cancer or progenitor stem cell". In multiple myeloma to define immunophenotyping features of these "cancer stem cells" with flow cytometry and to show their prognostic value and check for any relationship between cancer stem cell quantification and chemotherapy response are main aims of this study.
Conditions
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2016-01-01
- Completion
- 2016-01-01
- First posted
- 2013-03-28
- Last updated
- 2016-01-06
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT01820546. Inclusion in this directory is not an endorsement.